<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Almanac of Clinical Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Almanac of Clinical Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Альманах клинической медицины</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-0505</issn><issn publication-format="electronic">2587-9294</issn><publisher><publisher-name xml:lang="en">Moscow Regional Research and Clinical Institute (MONIKI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">284</article-id><article-id pub-id-type="doi">10.18786/2072-0505-2014-30-18-24</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ACTUAL PROBLEMS OF NEPHROLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ НЕФРОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CLINICAL SIGNIFICANCE OF SERUM AND URINARY HEAT SHOCK PROTEIN 70 LEVEL ASSESSMENT IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS</article-title><trans-title-group xml:lang="ru"><trans-title>КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ ОПРЕДЕЛЕНИЯ СЫВОРОТОЧНОГО И МОЧЕВОГО ПОКАЗАТЕЛЕЙ БЕЛКА ТЕПЛОВОГО ШОКА-70 У БОЛЬНЫХ ХРОНИЧЕСКИМ ГЛОМЕРУЛОНЕФРИТОМ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chebotaryova</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Чеботарева</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bobkova</surname><given-names>I. N.</given-names></name><name xml:lang="ru"><surname>Бобкова</surname><given-names>И. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Neprintseva</surname><given-names>N. I.</given-names></name><name xml:lang="ru"><surname>Непринцева</surname><given-names>Н. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kozlovskaya</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Козловская</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2014</year></pub-date><issue>30</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>18</fpage><lpage>24</lpage><history><date date-type="received" iso-8601-date="2016-03-01"><day>01</day><month>03</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-03-01"><day>01</day><month>03</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Chebotaryova N.V., Bobkova I.N., Neprintseva N.I., Kozlovskaya L.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Чеботарева Н.В., Бобкова И.Н., Непринцева Н.И., Козловская Л.В.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Chebotaryova N.V., Bobkova I.N., Neprintseva N.I., Kozlovskaya L.V.</copyright-holder><copyright-holder xml:lang="ru">Чеботарева Н.В., Бобкова И.Н., Непринцева Н.И., Козловская Л.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://almclinmed.ru/jour/article/view/284">https://almclinmed.ru/jour/article/view/284</self-uri><abstract xml:lang="en"><p>The levels of urinary heat shock protein-70 and serum antibodies to the heat shock protein-70 were assessed in 79 patients with different course variants of the chronic glomerulonephritis. The indices studied were higher in patients with an active course of the disease (expressed urinary and nephritic syndromes, especially if associated with transient renal disturbances which reflected the degree of lesion and activation of the renal self-defence system. Decrease of the serum level of antibodies to the heat shock protein-70 was an unfavorable factor of the nephrotic syndrome persistence despite the immunosuppressive therapy.</p></abstract><trans-abstract xml:lang="ru"><p>Уровни белка теплового шока-70 в моче и антител к белку теплового шока-70 в сыворотке крови были оценены у 79 больных с различными вариантами течения хронического гломерулонефрита. Изученные показатели были выше у больных с активным течением этого заболевания - выраженным мочевым и нефротическим синдромами, особенно при сочетании с преходящим нарушением функции почек, что отражает степень повреждения и активации механизмов самозащиты почки. Снижение уровня антител к белку теплового шока-70 в сыворотке крови являлось неблагоприятным прогностическим фактором персистирования нефротического синдрома, несмотря на проводимую иммуносупрессивную терапию.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хронический гломерулонефрит</kwd><kwd>chronic glomerulonephritis</kwd><kwd>нефротический синдром</kwd><kwd>nephrotic syndrome</kwd><kwd>самозащита почки</kwd><kwd>kidney self-defense</kwd><kwd>белок теплового шока-70</kwd><kwd>антитела к белку теплового шока-70</kwd><kwd>экскреция белка теплового шока-70 с мочой</kwd><kwd>heat shock protein 70 urinary excretion</kwd><kwd>heat shock protein 70</kwd><kwd>heat shock protein 70 antibody</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Мухин H.A., Ляшко В.Н., Маргулис Б.А. и др. Амилоидоз и антитела к белкам теплового шока//Тер. арх. 1992. №64. С.79-82.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Anderton S.M., van der Zee R., Prakken В. et al. Activation of T cells recognizing self 60-kDa heat shock protein can protect against experimental arthritis//J. Exp. Med. 1995. V.181. P.943-952.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Basu S., Binder R., Suto R. et al. Necrotic, but not apoptotic cell death releases heat shock proteins, with deliver a partial maturation signal to dendritic cells and activate the NFkB pathway//Int. Immunol. 2000. V.12. P.1539-1546.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Beck F.-X., Neuhofer W., Muller E. Molecular chaperones in the kidney: distribution, putative roles and regulation//Am. J. Physiol. Renal. Physiol. 2000. V.279. P.203-215.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Cowley B.D., Gudapaty S. Temporal alterations in regional gene expression after nephrotoxic renal injury//J. Lab. Clin. Med. 1995. V.125. P.187-199.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. de Kleer I.M., Wedderburn L.R., Taams L.S. et al. CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis//J. Immunol. 2004. V.172. P.6435-6443.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Detanico T., Rodrigues L., Sabritto A.C. et al. Mycobacterial heat shock protein 70 induces interleukin-10 production: immunomodulation of synovial cell cytokine profile and dendritic cell maturation//Clin. Exp. Immunol. 2004. V.135. P.336-342.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Dinda A.K., Mathur M., Guleria S. et al. Heat shock protein (HSP) expression and proliferation of tubular cells in end stage renal disease with and without haemodialysis//Nephrol. Dial. Transplant. 1998. V.13. P.99-105.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Dulin E., Barreno P.G., Guisasola M.C. Extracellular heat shock protein 70 (HSPA1A) and classical vascular risk factors in a general population//Cell Stress Chaperones. 2010. V.15. P.929-937.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Kitamura M., Fine L.G. The concept of glomerular self-defense//Kidney Int. 1999. V.55. P.1639-1671.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Komatsuda A., Wakui H., Imai H. et al. Renal localization of the constitutive 73-kDa heat shock protein in normal and PAN rats//Kidney Int. 1992. V.41. P.1204-1212.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Marzec L., Zdrojewski Z., Liberek T. et al. Expression of Hsp 72 protein in chronic kidney disease patients//Scand. J. Urol. Nephrol. 2009. V.43, No.5. P.400-408.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Miyata M., Sato H., Sato Y. et al. Significance of endogenous heat shock protein in adjuvant arthritis//J. Rheumatol. 1999. V.26. P.2210-2214.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Mueller T., Bidmon B., Pichler P. et al. Urinary heat shock protein-72 excretion in clinical and experimental renal ischemia//Pediatr. Nephrol. 2003. V.18. P.97-99.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Multhoff G., Hightower L.E. Cell surface expression of heat shock proteins and the immune response//Cell Stress Chaperones. 1996. V.l. P.167-176.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Rao D.V., Watson К., Jones G.L. Age-related attenuation in the expression of the major heat shock proteins in human peripheral lymphocytes//Mech. Ageing Dev. 1999. V.107. P.105-118.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. van Eden W., Tholet J.E.R., van der Zee R. et al. Cloning of the mycobacterial epitope recognized by T lymphocyte in adjuvant arthritis//Nature. 1988. V.331. P.171-173.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. van Eden W., van der Zee R., Prakken B. Heat shock proteins induce T cell regulation of chronic inflammation//Nature. 2005. V.5. P.318-330.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Venkataseshan V.S., Marquet E. Heat shock protein 72/73 in normal and diseased kidneys//Nephron. 1996. V.73. P.442-449.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Welch W.J. Mammalian stress response: Cell physiology, structure/function of stress proteins, and implication for medicine and disease//Physiol. Rev. 1992. V.72. P.1063-1081.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Wendling U., Paul Lvan der Zee R. et al. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induced IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue//J. Immunol. 2000. V.164. P.2711-2717.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Wu T., Tanguay R.M. Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?//Cell Stress Chaperones. 2006. V.ll, No.l. P.l-12.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. Zhang X., Xu Z., Zhou L. et al. Plasma levels of Hsp 70 and anti-Hsp70 antibody predict risk of coronary syndrome//Cell Stress Chaperones. 2010. V.15. P.675-686.</mixed-citation></ref></ref-list></back></article>
